PAK4 confers the malignance of cervical cancers and contributes to the cisplatin-resistance in cervical cancer cells via PI3K/AKT pathway

被引：0
|
作者：
Xiang-Rong Shu
Jing Wu
He Sun
Li-Qun Chi
Jin-Huan Wang
机构：
[1] Tianjin University,School of Pharmaceutical Science and Technology
[2] Tianjin Huanhu Hospital,undefined
[3] Haidian Maternal & Child Health Hospital,undefined
来源：
Diagnostic Pathology | / 10卷
关键词：
Cervical Cancer; Cervical Cancer Cell; Figo Stage; Cervical Cancer Patient; Caski Cell;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Butein suppresses cervical cancer growth through the PI3K/AKT/mTOR pathway
    Bai, Xue
    Ma, Yaxin
    Zhang, Guobin
    ONCOLOGY REPORTS, 2015, 33 (06) : 3085 - 3092
  • [32] S100A6 promotes the proliferation and migration of cervical cancer cells via the PI3K/Akt signaling pathway
    Li, Aifang
    Gu, Yue
    Li, Xueru
    Sun, Hui
    Zha, He
    Xie, Jiaqing
    Zhao, Jiali
    Huang, Mao
    Chen, Lu
    Peng, Qi
    Zhang, Yan
    Weng, Yaguang
    Zhou, Lan
    ONCOLOGY LETTERS, 2018, 15 (04) : 5685 - 5693
  • [33] Kaempferol Inhibits Cervical Cancer Cells by Inducing Apoptosis and Autophagy via Inactivation of the PI3K/AKT/mTOR Signaling Pathway
    Choi, Eun-young
    Han, Eun-ji
    Jeon, Su-ji
    Lee, Sang-woo
    Moon, Jun-mo
    Jung, Soo-hyun
    Park, Young-seok
    Park, Byung-kwon
    Kim, Byeong-soo
    Kim, Sang-ki
    Jung, Ji-youn
    ANTICANCER RESEARCH, 2024, 44 (07) : 2961 - 2972
  • [34] Knockdown of TRIM11 suppresses cell progression and apoptosis of cervical cancer cells via PI3K/AKT pathway
    Liu, Wenfeng
    Wu, Zuoli
    Wang, Lijuan
    Wang, Qijun
    Sun, Xiuhua
    Niu, Shufeng
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (09): : 10328 - 10340
  • [35] FNDC5 inhibits malignant growth of human cervical cancer cells via restraining PI3K/AKT pathway
    Li, Na
    Wang, Xiao-Li
    Ge, Rui
    Wang, Yu
    Tian, Xiao-Lei
    Zhu, Guo-Qing
    Zhou, Bing
    JOURNAL OF CELLULAR PHYSIOLOGY, 2024, 239 (06)
  • [36] Cervical cancer harboring a Rb1 mutation may sensitize to cisplatin via PI3K/AKT pathway by regulating apoptosis.
    Luo, Peng
    Zou, Jingwen
    Bu, Junguo
    Meng, Hui
    Chen, Jie
    Zhang, Jian
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [37] SNHG7 mediates cisplatin-resistance in non-small cell lung cancer by activating PI3K/AKT pathway
    Chen, K.
    Abuduwufuer, A.
    Zhang, H.
    Luo, L.
    Suotesiyali, M.
    Zou, Y.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (16) : 6935 - 6943
  • [38] Growth factor progranulin promotes tumorigenesis of cervical cancer via PI3K/Akt/mTOR signaling pathway
    Feng, Tingting
    Zheng, Lin
    Liu, Feng
    Xu, Xiaoying
    Mao, Sheng
    Wang, Xiao
    Liu, Juan
    Lu, Yi
    Zhao, Weiming
    Yu, Xiuping
    Tang, Wei
    ONCOTARGET, 2016, 7 (36) : 58381 - 58395
  • [39] Fucoxanthin induces apoptosis in human cervical cancer cell line HeLa via PI3K/Akt pathway
    Ye, Guoliu
    Lu, Qin
    Zhao, Weidong
    Du, Danli
    Jin, Lijie
    Liu, Yusheng
    TUMOR BIOLOGY, 2014, 35 (11) : 11261 - 11267
  • [40] Peroxiredoxin 4 contributes to radiation resistance of prostate cancer cells through the activation of the PI3K/AKT signaling pathway.
    Ding, Na
    Jiang, Hong
    Thapa, Pratik
    Hao, Yanning
    Alshahrani, Aziza
    Yang, Shengming
    Rangnekar, Vivek M.
    Liu, Xiaoqi
    Wei, Qiou
    CLINICAL CANCER RESEARCH, 2021, 27 (08)
12345